PROMENTIS PHARMACEUTICALS, INC.

Basic Information

826 N. Plankinton Ave
Milwaukee, WI, -

Company Profile

n/a

Additional Details

Field Value
DUNS: 794082193
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Targeting System Xc- for the Treatment of Schizophrenia

    Amount: $1,800,000.00

    DESCRIPTION (provided by applicant): Schizophrenia is a chronic and debilitating disorder that impacts nearly 1% of the world's population. The burden on the families and caregivers of patients i ...

    SBIR Phase II 2012 Department of Health and Human Services
  2. Development of Compounds Targeting xc- for the Treatment of Schizophrenia

    Amount: $508,369.00

    DESCRIPTION (provided by applicant): Schizophrenia is a debilitating disorder that affects almost 1% of the world's population. The burden on the families and caregivers of patients is immense, and th ...

    SBIR Phase I 2008 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government